LDS/Medical Tests/Hereditary Hemorrhagic Telangiectasia, ENG Gene Mutation Analysis

Hereditary Hemorrhagic Telangiectasia, ENG Gene Mutation Analysis

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular disorder leading to telangiectases and arteriovenous malformations of skin, mucosa, and viscera. Arteriovenous malformations (AVMs) are direct connections between arteries and veins that lack intervening capillary beds. The clinical manifestations include spontaneous and recurrent nosebleeds (epistaxis) and telangiectases (small AVMs) on the lips, tongue, buccal mucosa, face, chest, and fingers. Large AVMs in the lungs, liver, GI tract and central nervous system may cause symptoms due to mass effect, bleeding or shunting. Patients may experience transient ischemic attacks, embolic strokes, cerebral hemorrhage, seizures, paralysis, heart failure, hemoptysis, hemothorax, and GI bleeding. The incidence of HHT is between 1 in 5,000 and 1 in 10,000 people and affects men, and women of all ethnic groups.

To date all of the mutations associated with HHT occur in genes that encode proteins involved in the transforming growth factor beta (TGFß) signaling pathway, including ACVRL1, ENG, GDF2 and SMAD4. While HHT patients may demonstrate any or all of the clinical features of the disorder there are some differences depending on the gene mutation involved. Patients with mutations in the ENG gene that encodes for endoglin have HHT Type 1 which has an earlier age of onset and higher incidence of lung and CNS AVMs. HHT Type 2 is caused by mutations in ACVRL1 and patients tend to have a higher incidence of hepatic AVMs, and pulmonary hypertension. Patients with mutations in SMAD4 may have features of juvenile polyposis syndrome (JPS), HHT or both.

Mutation in ENG gene is mostly associated with type 1 HHT. ENG gene encodes for endoglin protein found on the surface of cells, especially in the lining of developing arteries. Endoglin is known to form a complex with growth factors and other proteins involved in the development of blood vessels. Mutations on ENG gene are either decreasing or impairing its function. The shortage of functional endoglin appears to interfere with the development of boundaries between arteries and veins, resulting in the signs and symptoms of hereditary hemorrhagic telangiectasia type 1.

  • Diagnostic confirmation of HHT in symptomatic individuals
  • Carrier screening in family members of an affected patient
  • For the prenatal genetic testing in at risk pregnancies
  • For pre-implantation genetic diagnosis of HHT
  • To assist with prognosis, clinical management and surveillance for disease features based on the genetic variant involved.
Any mutation or pathogenic variants in ENG gene is supportive of diagnosis of hereditary hemorrhagic telangiectasia. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants.

Negative for mutations or pathogenic variants in ENG gene

Sequence analysis by next generation sequencing or bi-directional sequencing. ENG gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.

Whole blood (EDTA).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: Unacceptable
Vascular Malformations Panel, Pulmonary Artery Hypertension (PAH) Panel, Hereditary Hemorrhagic Telangiectasia (HHT) Panel.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Genet Med. 2011;13: 607-16. [PMID: 21546842]
  • J Thromb Haemost. 2010;8: 1447-56. [PMID: 20345718]
  • Ir J Med Sci. 2009;178: 135-46. [PMID: 18923886]
  • Eur J Hum Genet. 2009;17: 860-71. [PMID: 19337313]
  • Gastroenterol Nurs. 2007;30: 293-9; quiz 300-1. [PMID: 17724405]
  • Genetics Home Reference. Available at: https://ghr.nlm.nih.gov/condition/hereditary-hemorrhagic-telangiectasia#
  • GeneReviews® [Internet]. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1351/
  • Genetics Home Reference. Available at: https://ghr.nlm.nih.gov/gene/ACVRL1#
  • Genetics Home Reference. Available at: https://ghr.nlm.nih.gov/gene/ENG#